| ASPsiRNA ID | Pairing of target region (top) and ASP-siRNA (bottom) | Efficacy (mut)(%) | Efficacy (wt) (%) | Diff | Gene | Disease | Mutation | RefSNP | Analysis | Pubmed ID |
|---|---|---|---|---|---|---|---|---|---|---|
| aspsirna2108 | AGCUGUUGGCGUAGGCAAG UCGACAACCGCAUCCGUUC |
10 | 33 | -23 | KRAS | Cancer | c.35G>T,p.Gly12Val | rs12191352 | 
|
|
| aspsirna2129 | AGCUGUUGGCGUAGGCAAG UCGACAACCGCAUCCGUUC |
10 | 33 | -23 | KRAS | Cancer | c.35G>T,p.Gly12Val | rs12191352 |
|
|
| aspsirna0354 | UCAAAGUUCCAGCUGGGAU AGUUUCAAGGUCGACCCUA |
10 | 5 | 5 | COL3A1 | Vascular Ehlers-Danlos Syndrome (vEDs) | c.764G>T,p.Gly255Val | rs58777960 |
|
|
| aspsirna3779 | AAAGUUGCGCGGAGGAGUU UUUCAAAGCGCCUCCUCAA |
90 | 0 | 90 | PPIB/Cyclophilin B | PPIB-Related Osteogenesis Imperfecta (Type IX) | NA | NA |
|
